Close

Analyst Ratings for Rexahn Pharmaceuticals Inc. (RNN)

RNN Rating Summary

  |   Expand Research on RNN
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/28/2018 Brookline Capital Markets Kumaraguru Raja New Coverage Buy
(N/A)
10.00
(N/A)
1.11
(5.24)
372.07% Details
10/4/2018 IFS Securities David Bouchey Upgrade Strong Buy
(Outperform)
6.00
(N/A)
1.85
(5.24)
183.24% Details
Like RNN Ratings? Also take a look at

RNN Ratings News